Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Dongjin JangSejoon LeeJaehyun LeeKiseong KimDoheon LeePublished in: J. Biomed. Informatics (2016)
Keyphrases
- clinical trials
- disease diagnosis
- drug discovery
- pharmaceutical industry
- incomplete information
- drug resistance
- health care professionals
- chemical compounds
- clinically relevant
- drug design
- medical doctors
- diabetic patients
- cancer patients
- multiple sclerosis
- health care
- disease progression
- clinical guidelines
- clinical applications
- clinical data
- computer aided